HOOKIPA Pharma Inc.
HOOKDelisted Jul 29, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001760542
HOOKIPA Pharma Inc. was delisted on Jul 29, 2025; its insiders filed their last Form 4 on Oct 9, 2025; 27 institutions reported holding it in 13F filings for Q2 2025, worth $6.01M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in HOOKIPA Pharma Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
HOOK is no longer listed, and 13F filings after Q2 2025 list far fewer holders. See Q2 2025
- Institutional holders
- 6
- −21 vs. Q2 2025
- Shares held
- 892.6K
- −3.90M (−81.4%) vs. Q2 2025
- Total value
- $824.4K
- −$5.18M (−86.3%) vs. Q2 2025
- New holders
- 2
- 1 more added
- Sold out
- 23
- 1 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $824.4K |
| Q2 2025 | 27 | $6.01M |
| Q1 2025 | 32 | $5.30M |
| Q4 2024 | 38 | $10.7M |
| Q3 2024 | 35 | $20.2M |
| Q2 2024 | 41 | $20.9M |
| Q1 2024 | 47 | $25.5M |
| Q4 2023 | 41 | $28.4M |
| Q3 2023 | 45 | $25.7M |
| Q2 2023 | 53 | $40.1M |
| Q1 2023 | 45 | $16.4M |
| Q4 2022 | 55 | $19.3M |
| Q3 2022 | 54 | $38.3M |
| Q2 2022 | 58 | $48.0M |
| Q1 2022 | 74 | $69.9M |
| Q4 2021 | 72 | $32.7M |
| Q3 2021 | 72 | $74.8M |
| Q2 2021 | 71 | $114.6M |
| Q1 2021 | 62 | $156.1M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding HOOKIPA Pharma Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 498,625 | $461.2K | 0.25% | 00.0% | Unchanged |
| JBF Capital, Inc. | 347,000 | $321.0K | 0.05% | +347,000 | New |
| Acadian Asset Management LLC | 28,020 | $25.0K | 0.00% | −27,715−49.7% | Reduced |
| XTX Topco Ltd | 18,056 | $16.7K | 0.00% | +18,056 | New |
| Advisor Group Holdings, Inc. | 513 | $466 | 0.00% | +13+2.6% | Added |
| Simplex Trading, LLC | 341 | $0 | 0.00% | 00.0% | Unchanged |
| Gilead Sciences, Inc. | 0 | $0 | 0.00% | −1,875,945−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −812,814−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −566,640−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −334,030−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −300,819−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −73,341−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −52,996−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −45,570−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −37,265−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −28,852−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −23,948−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −19,247−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −16,967−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −15,661−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −12,250−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,688−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,481−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −815−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −481−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −13−100.0% | Sold out |